Document Detail

State of the Art Management of Transfusion-Related Acute Lung Injury (TRALI).
MedLine Citation:
PMID:  22621274     Owner:  NLM     Status:  Publisher    
Transfusion-Related Acute Lung Injury (TRALI) is the leading cause of transfusion-related mortality in most developed countries. Despite this fact, well-designed investigations on specific management strategies for TRALI are lacking. Indeed, current recommendations are primarily based on data extrapolated from trials of the histo-pathologically similar Acute Lung Injury and Acute Respiratory Distress Syndromes. The cornerstone of TRALI management is supportive care with oxygen supplementation and ventilatory assistance when needed. When mechanical ventilation is required, attenuating additional ventilator-induced lung injury through the avoidance of high tidal volumes and elevated airway pressures, with additional measures such as positive end-expiratory pressure to prevent low-volume shear stress injury, are recommended. The literature is not currently sufficient to support either corticosteroids or statins as effective therapies in TRALI. Conservative fluid practices are desirable, provided care is taken to avoid hypotension. Preventative strategies have shown the most promise in mitigating this transfusion-related pulmonary complication. Specifically, conservative transfusion practices and deferral of high-plasma component donors who have, or at high risk of having, anti-human leukocyte antigen and/or anti-human neutrophil antigen antibodies have meaningfully impacted the incidence of TRALI. Future considerations for patients who are at increased risk for developing TRALI may include therapies such as anti-platelet agents and alternatives to traditional blood components such as prothrombin complex concentrates (PCC). However, these potential TRALI prevention strategies are insufficiently studied, have unclear risk/benefit profiles and cannot be currently recommended.
Andrew D Goldberg; Daryl J Kor
Related Documents :
15502384 - Effects of enhanced external counterpulsation on hemodynamics and its mechanism.
9124444 - Atrial systolic pressure, as well as stretch, is a principal stimulus for release of anf.
15345664 - High intraindividual variation of b-type natriuretic peptide (bnp) and amino-terminal p...
9469794 - Blunted renal responses to atrial natriuretic peptide and its reversal by unclipping in...
468444 - Effects of tetrahydrocannabinol on arterial and intraocular hypertension.
11887974 - Episodes of st-segment depression is related to changes in ambulatory blood pressure an...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-22
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Fellow, Critical Care Medicine, Division of Critical Care Medicine, Mayo Clinic, 200 First Street S.W. Rochester, MN 55905.;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevention of Immune-mediated Transfusion-related Acute Lung Injury; from Bloodbank to Patient.
Next Document:  Association of tobacco use and periapical pathosis - a systematic review.